N-Hydroxy-2-acetamidofluorene (BioDeep_00000005359)

 

Secondary id: BioDeep_00001868495

human metabolite blood metabolite


代谢物信息卡片


N-(9H-fluoren-2-yl)-N-hydroxyacetamide

化学式: C15H13NO2 (239.0946)
中文名称:
谱图信息: 最多检出来源 Homo sapiens(blood) 45.73%

分子结构信息

SMILES: CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O
InChI: InChI=1S/C15H13NO2/c1-10(17)16(18)13-6-7-15-12(9-13)8-11-4-2-3-5-14(11)15/h2-7,9,18H,8H2,1H3

描述信息

同义名列表

13 个代谢物同义名

N-(9H-fluoren-2-yl)-N-hydroxyacetamide; N-Hydroxy-N-acetyl-2-aminofluorene; N-Fluoren-2-ylacetohydroxamic acid; 2-(N-Acetylhydroxylamino)fluorene; Fluorenyl-2-acethydroxamic acid; N-Fluoren-2-ylacetohydroxamate; 2-(N-Hydroxyacetamido)fluorene; N Hydroxy 2 acetamidofluorene; N-Hydroxy-2-acetamidofluorene; Fluorenyl-2-acethydroxamate; Hydroxyacetylaminofluorene; Hydroxyfluorenylacetamide; N-hydroxy-aaf



数据库引用编号

13 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(4)

BioCyc(0)

PlantCyc(0)

代谢反应

40 个相关的代谢反应过程信息。

Reactome(40)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 13 AFP, ALB, AR, CAT, CYP1A1, ERCC1, HPGDS, HPRT1, LPO, NAT2, SULT1C2, SULT1C4, SULT2A1
Peripheral membrane protein 1 CYP1A1
Endosome membrane 1 CTSD
Endoplasmic reticulum membrane 3 CYP1A1, HSP90B1, NRAS
Nucleus 7 ALB, AR, CENPK, ERCC1, HSP90B1, MPO, NAT2
cytosol 13 ALB, AR, CAT, CENPK, HPGDS, HPRT1, HSP90B1, NAT1, NAT2, NRAS, SULT1C2, SULT1C4, SULT2A1
centrosome 1 ALB
nucleoplasm 5 AR, CENPK, ERCC1, HPGDS, MPO
Cell membrane 3 NAT1, NAT2, NRAS
Lipid-anchor 1 NRAS
Cytoplasmic side 1 NRAS
Multi-pass membrane protein 2 NAT1, NAT2
Golgi apparatus membrane 1 NRAS
Synapse 1 NAT1
cell surface 1 NAT1
Golgi apparatus 2 ALB, NRAS
Golgi membrane 1 NRAS
lysosomal membrane 1 CTSD
mitochondrial inner membrane 1 CYP1A1
neuronal cell body 1 NAT2
presynaptic membrane 1 NAT1
smooth endoplasmic reticulum 1 HSP90B1
Cytoplasm, cytosol 2 SULT1C2, SULT1C4
Lysosome 3 CTSD, MPO, SULT1C2
plasma membrane 4 AR, NAT1, NAT2, NRAS
synaptic vesicle membrane 1 NAT1
Membrane 6 AR, CAT, HSP90B1, NAT1, NAT2, NRAS
apical plasma membrane 1 NAT1
axon 2 NAT1, NAT2
basolateral plasma membrane 3 LPO, NAT1, NAT2
extracellular exosome 9 ALB, CAT, CTSD, HPRT1, HSP90B1, LPO, MPO, NAT2, NRAS
endoplasmic reticulum 2 ALB, HSP90B1
extracellular space 6 AFP, ALB, CTSD, GH1, LPO, MPO
lysosomal lumen 1 CTSD
perinuclear region of cytoplasm 1 HSP90B1
mitochondrion 2 CAT, CYP1A1
protein-containing complex 4 ALB, AR, CAT, HSP90B1
intracellular membrane-bounded organelle 4 CAT, CYP1A1, HPGDS, MPO
Microsome membrane 1 CYP1A1
Secreted 4 AFP, ALB, GH1, LPO
extracellular region 7 ALB, CAT, CTSD, GH1, HSP90B1, LPO, MPO
neuronal cell body membrane 1 NAT1
mitochondrial matrix 1 CAT
anchoring junction 1 ALB
transcription regulator complex 1 NAT2
midbody 1 HSP90B1
Mitochondrion inner membrane 1 CYP1A1
Membrane raft 1 CTSD
focal adhesion 2 CAT, HSP90B1
Peroxisome 1 CAT
Peroxisome matrix 1 CAT
peroxisomal matrix 1 CAT
peroxisomal membrane 1 CAT
collagen-containing extracellular matrix 2 CTSD, HSP90B1
secretory granule 1 MPO
nuclear speck 1 AR
ciliary basal body 1 ALB
chromatin 1 AR
[Isoform 3]: Nucleus 1 ERCC1
centriole 1 ALB
spindle pole 1 ALB
chromosome, telomeric region 1 ERCC1
blood microparticle 1 ALB
Basolateral cell membrane 1 NAT1
endosome lumen 2 CTSD, GH1
Chromosome, centromere 1 CENPK
inner kinetochore 1 CENPK
tertiary granule membrane 1 NRAS
Melanosome 2 CTSD, HSP90B1
sperm plasma membrane 1 HSP90B1
azurophil granule 1 MPO
ficolin-1-rich granule lumen 2 CAT, CTSD
secretory granule lumen 1 CAT
endoplasmic reticulum lumen 3 AFP, ALB, HSP90B1
platelet alpha granule lumen 1 ALB
specific granule lumen 1 CTSD
tertiary granule lumen 1 CTSD
azurophil granule lumen 1 MPO
chromosome, centromeric region 1 CENPK
[Isoform 2]: Cytoplasm 1 ERCC1
Sarcoplasmic reticulum lumen 1 HSP90B1
phagocytic vesicle lumen 1 MPO
[Isoform 1]: Nucleus 1 ERCC1
external side of apical plasma membrane 1 NAT2
[Isoform 4]: Nucleus 1 ERCC1
endocytic vesicle lumen 1 HSP90B1
growth hormone receptor complex 1 GH1
catalase complex 1 CAT
endoplasmic reticulum chaperone complex 1 HSP90B1
ERCC4-ERCC1 complex 1 ERCC1
nucleotide-excision repair complex 1 ERCC1
nucleotide-excision repair factor 1 complex 1 ERCC1
NatA complex 1 NAT2
ciliary transition fiber 1 ALB


文献列表

  • Melissa Runge-Morris, Thomas A Kocarek. Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs. PPAR research. 2009; 2009(?):728941. doi: 10.1155/2009/728941. [PMID: 19680455]
  • K Sugihara, S Kitamura, S Ohta, K Tatsumi. Reduction of hydroxamic acids to the corresponding amides catalyzed by rabbit blood. Xenobiotica; the fate of foreign compounds in biological systems. 2000 May; 30(5):457-67. doi: 10.1080/004982500237479. [PMID: 10875680]
  • R C Kolanczyk, H R Gutmann, I R Rutks. Effect of bovine serum albumin on the extent of ortho rearrangement of N-(sulfooxy)-2-fluorenylacetamide and of enzymatically activated N-hydroxy-2-fluorenylacetamide and on the binding of reactive esters to nucleic acids. Chemical research in toxicology. 1992 Mar; 5(2):274-9. doi: 10.1021/tx00026a020. [PMID: 1643258]
  • R C Kolanczyk, I R Rutks, H R Gutmann. The catalytic effect of bovine serum albumin on the ortho rearrangement of the potential ultimate carcinogen, N-(sulfooxy)-2-(acetylamino)fluorene, generated enzymatically from N-hydroxy-2-(acetylamino)fluorene and evidence for substrate specificity of the enzymatic sulfonation of arylhydroxamic acids. Chemical research in toxicology. 1991 Mar; 4(2):187-94. doi: 10.1021/tx00020a010. [PMID: 1782347]
  • E D Kroese, G Bannenberg, P Dogterom, A B Noach, J F Nagelkerke, J H Meerman. Lipid peroxidation and protein thiol depletion are not involved in the cytotoxicity of N-hydroxy-2-acetylaminofluorene in isolated rat hepatocytes. Biochemical pharmacology. 1990 Oct; 40(8):1885-92. doi: 10.1016/0006-2952(90)90370-z. [PMID: 2242021]
  • B A Smith, H R Gutmann, J R Springfield. Catalytic effect of serum albumin on the o-rearrangement of N-sulfooxy-2-acetylaminofluorene, a potential hepatocarcinogen in the rat, to nonmutagenic sulfuric acid esters of o-amidofluorenols. Biochemical pharmacology. 1989 Nov; 38(22):3987-94. doi: 10.1016/0006-2952(89)90678-3. [PMID: 2597180]
  • N Sawada, T Ishikawa. Reduction of potential for replicative but not unscheduled DNA synthesis in hepatocytes isolated from aged as compared to young rats. Cancer research. 1988 Mar; 48(6):1618-22. doi: NULL. [PMID: 3345532]
  • J H Meerman, C Nijland, G J Mulder. Sex differences in sulfation and glucuronidation of phenol, 4-nitrophenol and N-hydroxy-2-acetylaminofluorene in the rat in vivo. Biochemical pharmacology. 1987 Aug; 36(16):2605-8. doi: 10.1016/0006-2952(87)90538-7. [PMID: 3606659]
  • K Tatsumi, S Kitamura. N-hydroxy-2-acetylaminofluorene as effective inhibitor of aldehyde oxidase. Biochemical and biophysical research communications. 1986 Jul; 138(1):312-7. doi: 10.1016/0006-291x(86)90281-0. [PMID: 3741414]
  • S Yokoyama, M Satoh, B Lombardi. Bile ductular cells and the phenotypic heterogeneity of the population of hepatic non-parenchymal epithelial cells induced in rats by chemical carcinogens. Carcinogenesis. 1986 Jul; 7(7):1215-9. doi: 10.1093/carcin/7.7.1215. [PMID: 2424628]
  • T J Flammang, F F Kadlubar. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases. Carcinogenesis. 1986 Jun; 7(6):919-26. doi: 10.1093/carcin/7.6.919. [PMID: 3708755]
  • V T Vu, P H Grantham, P P Roller, W D Hankins, P J Wirth, S S Thorgeirsson. Formation of DNA adducts from N-acetoxy-2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in rat hemopoietic tissues in vivo. Cancer research. 1986 Jan; 46(1):233-8. doi: . [PMID: 3940194]
  • J H Meerman, R B Tijdens. Effect of glutathione depletion on the hepatotoxicity and covalent binding rat liver macromolecules of N-hydroxy-2-acetylaminofluorene. Cancer research. 1985 Mar; 45(3):1132-9. doi: . [PMID: 2578873]
  • G M Groothuis, J G Weitering, M J Hardonk, D K Meijer. Heterogeneity of rat hepatocytes in transport and hepatic binding of asialoalkaline phosphatase studied after induction of selective acinar damage by N-hydroxy-2-acetylaminofluorene and carbon tetrachloride. Biochemical pharmacology. 1983 Sep; 32(18):2721-7. doi: 10.1016/0006-2952(83)90082-5. [PMID: 6626243]
  • N M El-Torkey, E K Weisburger. Influence of disulfiram on mutagenicity of the urinary metabolites of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the Salmonella test system. Mutation research. 1983 Jul; 118(1-2):1-6. doi: 10.1016/0165-1218(83)90110-6. [PMID: 6346083]
  • C Y Wang, E M Linsmaier-Bednar, C D Garner. Inhibition of 4-nitroquinoline 1-oxide induced unscheduled DNA synthesis in primary cultures of rat urothelial cells by dicumarol and pyrophosphate. Chemico-biological interactions. 1982 Oct; 42(1):79-84. doi: 10.1016/0009-2797(82)90143-0. [PMID: 6185243]
  • F A Beland, K L Dooley, C D Jackson. Persistence of DNA adducts in rat liver and kidney after multiple doses of the carcinogen N-hydroxy-2-acetylaminofluorene. Cancer research. 1982 Apr; 42(4):1348-54. doi: . [PMID: 6949639]
  • J H Meerman, F A Beland, B Ketterer, S K Srai, A P Bruins, G J Mulder. Identification of glutathione conjugates formed from N-hydroxy-2-acetylaminofluorene in the rat. Chemico-biological interactions. 1982 Mar; 39(2):149-68. doi: 10.1016/0009-2797(82)90118-1. [PMID: 7060226]
  • B P Moore, R M Hicks, M A Knowles, S Redgrave. Metabolism and binding of benzo(a)pyrene and 2-acetylaminofluorene by short-term organ cultures of human and rat bladder. Cancer research. 1982 Feb; 42(2):642-8. doi: . [PMID: 6275985]
  • P Rio, S Bazgar, M Leng. Detection of N-hydroxy-2-acetylaminofluorene-DNA adducts in rat liver measured by radioimmunoassay. Carcinogenesis. 1982; 3(2):225-7. doi: 10.1093/carcin/3.2.225. [PMID: 6978201]
  • T V Reddy, E K Weisburger, S S Thorgeirsson. Mutagenic activation of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in subcellular fractions from X/Gf mice. Journal of the National Cancer Institute. 1980 Jun; 64(6):1563-9. doi: 10.1093/jnci/64.6.1563. [PMID: 6929392]
  • J E Steward, R A Floyd. The deacetylation of N-hydroxy-2-acetylaminofluorene by rat liver microsomes and carboxyl esterase. Cancer biochemistry biophysics. 1980; 5(1):47-53. doi: . [PMID: 6260332]
  • M K Samson, R L Stephens, S Rivkin, M Opipari, T Maloney, C W Groppe, R Fisher. Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group Study. Cancer treatment reports. 1979 Sep; 63(9-10):1663-7. doi: . [PMID: 91435]
  • C E Castro, I C Felkner, S P Yang. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium. Cancer research. 1978 Sep; 38(9):2836-41. doi: NULL. [PMID: 354780]
  • H A Schut, P J Wirth, S S Thorgeirsson. Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat. Molecular pharmacology. 1978 Jul; 14(4):682-92. doi: NULL. [PMID: 683178]
  • L A Poirier, P H Grantham, A E Rogers. The effects of a marginally lipotrope-deficient diet on the hepatic levels of S-adenosylmethionine and on the urinary metabolites of 2-acetylaminofluorene in rats. Cancer research. 1977 Mar; 37(3):744-8. doi: . [PMID: 65217]
  • M L Hopp, M Matsumoto, C Lee, R Oyasu. Absorption and protein binding of N-2-fluorenylacetamide and its metabolites in the bladder of rabbit. Journal of the National Cancer Institute. 1977 Feb; 58(2):281-5. doi: 10.1093/jnci/58.2.281. [PMID: 833876]
  • R A Floyd, L M Soong, R N Walker, M Stuart. Lipid hydroperoxide activation of N-hydroxy-N-acetylaminofluorene via a free radical route. Cancer research. 1976 Aug; 36(8):2761-7. doi: ". [PMID: 1277186]
  • L C Mohan, P H Grantham, E K Weisburger, J H Weisburger, J B Idoine. Mechanisms of the inhibitory action of p-hydroxyacetanilide on carcinogenesis by N-2-fluorenylacetamide or N-hydroxy-N-2-fluorenylacetamide. Journal of the National Cancer Institute. 1976 Apr; 56(4):763-8. doi: 10.1093/jnci/56.4.763. [PMID: 815562]
  • C W Olive, C M King. Evidence for a second arylhydroxamic acid acyltransferase species in the small intestine of the rat. Chemico-biological interactions. 1975 Dec; 11(6):599-604. doi: 10.1016/0009-2797(75)90034-4. [PMID: 1201619]
  • M Nozaki. [Combined use of bucolome and pyrazolone derivatives (1). Pharmacological activities and blood concentration]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 1975 Sep; 71(6):609-29. doi: NULL. [PMID: 281]
  • T Uemura, G Sakaguchi, T Ito, K Okazawa, S Sakai. Experimental diarrhea in cynomolgus monkeys by oral administration with Clostridium perfringens type A viable cells or enterotoxin. Japanese journal of medical science & biology. 1975 Jun; 28(3):165-77. doi: 10.7883/yoken1952.28.165. [PMID: 525]
  • G K Hanasono, M G Côté, G L Plaa. Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto- zotocin-diabetic rats. The Journal of pharmacology and experimental therapeutics. 1975 Mar; 192(3):592-604. doi: . [PMID: 164533]
  • R Kroes, J W Weiss, J H Weisburger. Immune suppression and chemical carcinogenesis. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1975; ?(52):65-75. doi: 10.1007/978-3-642-80940-8_9. [PMID: 796915]